Ultralife Corporation - Common Stock (ULBI)
Technology › Miscellaneous Electrical Machinery, Equipment & Supplies
Price History
Feb 9, 2026 — Jul 7, 2026Investment Snapshot
- Trading 99% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 0.8% — below-average profitability
- Revenue growing at 16% annually
Ultralife Corporation - Common Stock (ULBI) is a Technology company operating in Miscellaneous Electrical Machinery, Equipment & Supplies, listed on the NASDAQ , with a market capitalisation of $111 million . Key value metrics: P/E ratio 103.9, P/B ratio 0.86, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Ultralife Corporation - Common Stock — Fundamental Analysis Summary
Ultralife Corporation - Common Stock (ULBI) is currently trading 99% above its Graham Number of $3.36, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 103.9x.
On financial health, ULBI shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 0.8% (sector average: -1.0%), and manageable leverage with a debt-to-equity ratio of 0.34.
StockPik's composite Value Score for ULBI is 77/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ULBI reports a moderate gross margin of 23.2% (sector average: 40.2%) and a modest operating margin of 2.4%.
ULBI shows revenue growing at 16% year-over-year, with earnings declining at 193%.